Myelodysplastic syndrome/myeloproliferative neoplasm overlap syndrome

1 trials 1 recruiting MedDRA PT
1 Registered trials
1 Recruiting
1 Unique sponsors
1 Unique IMPs
1 Commercial trials
Drug classes (ATC)
— ATC code not specified 1
Mechanism of action (INN-stem analysis)
Unknown / small molecule 1 substance
Phase II: 1

Filter these 1 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 1 trials

Phase II

1 trial
  • Pharmacosmos A/S Commercial
    (S)-4,5-DIHYDRO-2-[2-HYDROXY-4-(3,6-DIOXAHEPTYLOXY)PHENYL]-4-METHYL-4-THIAZOLECARBOXYLIC ACID
    2023-507396-21-00 4 countries 2023 n=102
    Recruiting
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Pharmacosmos A/S Commercial 1 Phase II 1
New trials by year
2023
1
← All indication landscapes